Who we are

PharmaLex provides support across the value chain of pharmaceutical companies worldwide. 25 years of extensive experience in supporting our clients on critical projects has helped us to establish a network of local representatives in the MENA region who enable us to support our clients in the region.

Our value-driven clients solutions in MENA include:

  • Regulatory intelligence / regulatory strategy for expansion into new markets
  • Dossier gap assessment and compilation
  • CMC writing for dossier submissions
  • eCTD publishing
  • Regulatory labeling
  • Medical writing
  • Scientific advice / Scientific consulting with health authorities for establishing launch strategy
  • GxP audits to facilitate readiness for external agency audits, supplier audits, third party audits and QA / compliance consulting
  • Licensing – facilitating the import of products into the region
  • Consulting support, including language / translation services (specifically French and Arabic) as well as the provision of local expert resource in-house
  • Pharmacovigilance services – our local experts can provide support services right from setting up PSMF, training your Local Safety Officer (LSO), operational support from case processing, writing of RMP, PSUR, and signal detection for your marketed products.

Our Global Alliance Partner network, provides access to experienced local representatives who are professionals and leaders in their field of expertise and respective regions.

PharmaLex’s customer-centric approach provides better experience to our clients with dedicated resources supporting on the agreed business deliverables while ensuring timelines are met.

eCTD in the Middle East - online course
Jordan: Building the eCTD - training course

Local Contact

    Download Terms and Conditions

    What our clients say about us

    We are working with a number of large pharma companies and are looking to create a consortium of partners to collect feedback on expertise, availability and outcomes. If you would be interested in joining our consortium, please contact us on contact@pharmalex.com.

    • There was a close relationship between the regulatory strategy and the writing activities. You developed a fine-tuned regulatory strategy which will be a key factor to smooth the approval of our dossier.

      Large Pharma, Global
      VP Regulatory Strategy

    • We needed a partner to help us obtain device approval. PharmaLex have not only helped us achieve this but are now providing on-going post-marketing surveillance support. We would highly recommend them to anyone who needs specialist expertise.

      Med Device company, US
      Senior Regulatory Affairs Director

    • I just wanted to let you know that the recent EU Codes webinar was excellent. Rina presented a very complex and grey topic in the most clear and digestible manner – a sign of a true expert. The questions in the Q&A were sometimes a little ambiguous but Rina gave clear and relevant answers that provided real clarity.

      Richard Blackwell
      Medical Team Leader, Multi Tumor Franchise Roche Products Ltd

    • Rina and the team were brought in to help support us during the PMCPA complaint process and subsequent audits. Their expertise and approachability made this difficult process smooth. True professionals and a pleasure to work with!

      Astellas
      Head of Ethics and Compliance, Astellas Pharma Europe

    Related News